FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Supplemental Application (Vitruvias Therapeutics)

View source ↗

Summary

FDA approved a supplemental application for Bupropion Hydrochloride Extended-Release (XL) from Vitruvias Therapeutics under ANDA208652, approving changes to the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Nicotine Dependence
• Seasonal Affective Disorder

Drugs mentioned

• Bupropion hydrochloride extended-release (XL) (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (XL) (BUPROPION HYDROCHLORIDE)